Abstract Latent Epstein–Barr virus (EBV) infection has a substantial role in causing many
human disorders. The persistence of these viral genomes in all malignant cells, yet with the …

Within weeks of the first report of acquired immunodeficiency syndrome (AIDS) in 1981, it
was observed that these patients often had Kaposi sarcoma (KS), a hitherto rarely seen skin …

Epstein–Barr virus (EBV) is a human tumor virus and a model of herpesviral latency. The
virus efficiently infects resting human B lymphocytes and induces their continuous …

Epstein-Barr virus latent membrane protein 1 (LMP1) is expressed in multiple human
malignancies, including nasopharyngeal carcinoma and Hodgkin and immunosuppression …

Super-enhancers are clusters of gene-regulatory sites bound by multiple transcription
factors that govern cell transcription, development, phenotype, and oncogenesis. By …

Epstein-Barr virus (EBV) is a ubiquitous gammaherpesvirus which asymptomatically infects
the majority of the world population. Under immunocompromised conditions, EBV can …

The Epstein–Barr virus (EBV) is the first herpesvirus identified to be associated with human
cancers known to infect the majority of the world population. EBV-associated malignancies …

Epstein-Barr virus (EBV) causes endemic Burkitt lymphoma (BL) and immunosuppression-
related lymphomas. These B cell malignancies arise by distinct transformation pathways and …

The characteristic feature of healthy living organisms is the preservation of homeostasis.
Compelling evidence highlight that the DNA damage response and repair (DDR/R) and …

Epstein-Barr virus (EBV) transforms B cells to continuously proliferating lymphoblastoid cell
lines (LCLs), which represent an experimental model for EBV-associated cancers. EBV …